Just received this text yesterday from my friend Joe who saw the video on Anktiva "I'm almost in tears, Justin has been my friend for decades. Thank you so very much" Anktiva, the Cancer Bioshield. This is why we do what we do.

Finally an administration that understands the real world needs and taking real action to integrate technology to fix our broken health care system. Should have been done decades ago... but it's here now. We are in!!! youtube.com/watch?v=g7HACs…

Thank you Chris for all you do on behalf of patients.

Honored to participate in the initiative by CMS to Make Health Tech Great Again through NantIQ to launch the AI patient centered app to provide Americans access to their health records anytime anyplace across the healthcare system. Patient empowerment w AI CMSGov DrOzCMS

This initiative to establish intra-operability will transform healthcare and finally allow patients to access their data. Honored to be at this event today hosted by POTUS and CMS. To launch our patient centered AI app with real time data at point of care -NantIQ

Congrats to ⁦NantStudios⁩ for powering ⁦Battlefield⁩ 6 multiplayer launch at the most advanced virtual production campus in LA with unique shape-shifting LED stages & fiber for streaming. Built for film, TV, events & ads.The future of global e-sports in LA is here!

Shape shifting LED volume The first in the history of next generation movie / e sports production NantStudios. Innovation at work under nantworks. More to come

Trying hard for the cancer community to understand a universal truth that without the protection of Natural Killer cells and T cells patients are at risk. And without those cells fighting memory T cells won’t develop for a long duration of cancer free status. In the end patient’s

Reach out to CSSIFM.org Unfortunately we are now at 10,000 requests and counting. Your doctor could access Expanded Access and the only other option if he can’t do this as of now unfortunately is in LA.

Sorry for the pause in Cancer Decoded. Have been busy reviewing amazing data in multiple different tumor types in patients receiving the Bioshield platform..from patients with brain tumors who failed current standards of care to rare forms of Lymphoma. News out this week.

Waldenstroms, a rare form of lymphoma where tumor cells can take over 90 percent of the bone marrow - patients at this stage of disease when all treatment fails are at life-threatening danger. News on the power of NKcells and Bioshield platform to the rescue coming soon.

COMPLETE RESPONSES WITH NK CELL THERAPY. The power of the Bioshield platform. A tumor agnostic chemo free paradigm change by treating the immune system. Lymphoma trial is open. Contact CSSIFM to enroll. Next news coming - glioblastoma.

The power of NK cells. After a single cycle of NK cells targeting the tumor the patient with a rare lymphoma (WM) -90 percent of bone marrow infiltrated ( left PET scan) achieved a COMPLETE RESPONSE ( right scan). Had failed all other therapy. The power of the BIOSHIELD platform.

Trial of Bioshield to explore treatment of Long Covid is open!! Please enquire via this form at cssifm.org and our team will respond to the many requests for Bioshield #anktiva #longcovid

Soon to be opening randomized trials for Glioblastoma and Prostate cancer with the Bioshield. Only way for us to address the deluge of requests and the regulatory burden imposed on us. Information coming soon.

For those who unfortunately have Long Covid either from the infection or vaccine we now have opened a trial with Anktiva Bioshield to explore if the NK cells we activate can clear the cells that may persist with virus . @ cssifm.org

Next randomized trial in preparation : patients with Glioblastoma ( brain tumor) who have failed all standards of care. Sadly the progression free survival in these patients is measured in a few months. Our goal is to change this with Anktiva and NK cell therapy. Trial coming